Search Results - "Daniele, Laszlo"

A MALT lymphoma prognostic index by Thieblemont, Catherine, Cascione, Luciano, Conconi, Annarita, Kiesewetter, Barbara, Raderer, Markus, Gaidano, Gianluca, Martelli, Maurizio, Laszlo, Daniele, Coiffier, Bertrand, Lopez Guillermo, Armando, Torri, Valter, Cavalli, Franco, Johnson, Peter W, Zucca, Emanuele

“…There are no widely accepted prognostic indices for extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT). This study aimed to develop…”
Get full text

Chemotherapy-based versus chemotherapy-free stem cell mobilization (± plerixafor) in multiple myeloma patients: an Italian cost-effectiveness analysis by Lazzaro, Carlo, Castagna, Luca, Lanza, Francesco, Laszlo, Daniele, Milone, Giuseppe, Pierelli, Luca, Saccardi, Riccardo

“…Given the availability and efficacy of the mobilizing agent plerixafor in augmenting hematopoietic progenitor cell mobilization with granulocyte…”
Get full text

Addition of Rituximab to Chlorambucil Produces Superior Event-Free Survival in the Treatment of Patients With Extranodal Marginal-Zone B-Cell Lymphoma: 5-Year Analysis of the IELSG-19 Randomized Study by ZUCCA, Emanuele, CONCONI, Annarita, PILERI, Stefano A, COPIE-BERGMAN, Christiane, CAMPO, Elias, JACK, Andrew, FLORIANI, Irene, JOHNSON, Peter, MARTELLI, Maurizio, CAVALLI, Franco, MARTINELLI, Giovanni, THIEBLEMONT, Catherine, LASZLO, Daniele, LOPEZ-GUILLERMO, Armando, BOUABDALLAH, Reda, COIFFIER, Bertrand, SEBBAN, Catherine, JARDIN, Fabrice, VITOLO, Umberto, MORSCHHAUSER, Franck

“…Apart from localized gastric disease, there is no consensus on standard initial treatment of mucosa-associated lymphoid tissue lymphoma. The IELSG-19 study…”
Get full text

Heterogeneity of treatment effect on patients’ long-term outcome according to pathological response type in neoadjuvant RCTs for breast cancer. by Pala, Laura, Sala, Isabella, Pagan, Eleonora, De Pas, Tommaso, Zattarin, Emma, Catania, Chiara, Cocorocchio, Emilia, Rossi, Giovanna, Laszlo, Daniele, Ceresoli, Giovanni, Canzian, Jacopo, Valenzi, Elena, Bagnardi, Vincenzo, Conforti, Fabio

“…To provide evidence explaining the poor association between pCR and patients’ long-term outcome at trial-level in neoadjuvant RCTs for breast cancer (BC), we…”
Get full text

Disposal of the residual autologous HSC units: Results of a survey carried out two years after the publication of a national policy in Italy by Perseghin, Paolo, Laszlò, Daniele, Bonifazi, Francesca, Introna, Martino, Accorsi, Patrizia, Petrini, Carlo, Lombardini, Letizia

Get full text

Long-active granulocyte colony-stimulating factor for peripheral blood hematopoietic progenitor cell mobilization by Martino, Massimo, Laszlo, Daniele, Lanza, Francesco

“…Peg-filgrastim (PEG-FIL), a polyethylene glycol-conjugated form of granulocyte colony-stimulating factor (G-CSF), has been introduced in clinical practice and…”
Get more information

Exon-18-EGFR Mutated Transformed Small-Cell Lung Cancer: A Case Report and Literature Review by Digiacomo, Nunzio, De Pas, Tommaso, Rossi, Giovanna, Bossi, Paola, Stucchi, Erika, Conforti, Fabio, Cocorocchio, Emilia, Laszlo, Daniele, Pala, Laura, Zattarin, Emma, Catania, Chiara

“…Small-cell lung cancer (SCLC) transformation from EGFR mutant adenocarcinoma is a rare entity that is considered to be a new phenotype of SCLC. While…”
Get full text

Clinical Activity of Rituximab in Gastric Marginal Zone Non-Hodgkin's Lymphoma Resistant to or Not Eligible for Anti–Helicobacter Pylori Therapy by MARTINELLI, Giovanni, LASZLO, Daniele, ZUCCA, Emanuele, FERRERI, Andrés J. M, PRUNERI, Giancarlo, PONZONI, Maurilio, CONCONI, Annarita, CROSTA, Cristiano, PEDRINIS, Ennio, BERTONI, Francesco, CALABRESE, Liliana

“…Preliminary results using rituximab in extranodal marginal zone (MALT) non-Hodgkin's lymphoma (NHL) patients seem to indicate a relevant clinical activity. Aim…”
Get full text

Low-Dose Cyclophosphamide versus Intermediate-High-Dose Cyclophosphamide versus Granulocyte Colony-Stimulating Factor Alone for Stem Cell Mobilization in Multiple Myeloma in the Era of Novel Agents: A Multicenter Retrospective Study by Zannetti, Beatrice Anna, Saraceni, Francesco, Cellini, Claudia, Fabbri, Elisabetta, Monaco, Federica, Guarini, Attilio, Laszlo, Daniele, Martino, Massimo, Olivieri, Attilio, Imola, Manuela, Tosi, Patrizia, Chiarucci, Martina, Zuffa, Eliana, Lanza, Francesco

“…•Autologous stem cell transplantation is the standard of care for multiple myeloma.•The optimal stem cell mobilization strategy remains a matter of…”
Get full text

Rituximab and Subcutaneous 2-Chloro-2′-Deoxyadenosine Combination Treatment for Patients With Waldenström Macroglobulinemia: Clinical and Biologic Results of a Phase II Multicenter Study by LASZLO, Daniele, ANDREOLA, Giovanna, CALABRESE, Liliana, BILLIO, Atto, BERTOLINI, Francesco, MARTINELLI, Giovanni, RIGACCI, Luigi, FABBRI, Alberto, RABASCIO, Cristina, MANCUSO, Patrizia, PRUNERI, Giancarlo, RADICE, Davide, PINTO, Antonello, FRIGERI, Ferdinando

“…To assess the efficacy of 2-chloro-2'-deoxyadenosine (2-CdA) given subcutaneously (SC) in combination with rituximab in the treatment of newly…”
Get full text

Second Allogeneic Bone Marrow Transplantation in Acute Leukemia: Results of a Survey by the European Cooperative Group for Blood and Marrow Transplantation by BOSI, Alberto, LASZLO, Daniele, JOUET, Jean Pierre, FRASSONI, Francesco, LABOPIN, Myriam, REFFEIRS, Josy, MICHALLET, Mauricette, GLUCKMAN, Eliane, ALESSANDRINO, Paolo Emilio, LOCATELLI, Franco, VERNANT, Jean Paul, SIERRA, Jorge

“…Leukemic relapse is the most frequent cause of treatment failure after allogeneic hematopoietic stem-cell transplantation (HSCT). To identify prognostic…”
Get full text

Screening of related donors and peripheral blood stem cell collection practices at different Italian apheresis centres by Coluccia, Paola, Crovetti, Giovanni, Del Fante, Claudia, Dallavalle, Franco Maria, Laszlò, Daniele, Ferremi, Piero, Marenchino, Daniele, Santoleri, Luca, De Filippo, Concetto, Mattana, Flavia, Mariani, Luigi, Perseghin, Paolo, Ravagnani, Fernando

“…Recommendations on eligibility criteria for donation of haematopoietic stem cells, management of collection of the cells and follow-up mainly concern unrelated…”
Get full text

Gender-Based Differences in the Efficacy of Anti-EGFR/BRAF/MEK Targeted Therapy in Patients with BRAF-Mutated Metastatic Colorectal Cancer by Pala, Laura, De Pas, Tommaso, Cocorocchio, Emilia, Catania, Chiara, Ceresoli, Giovanni, Laszlo, Daniele, Zattarin, Emma, Rossi, Giovanna, Conforti, Fabio

Get full text

Immune-checkpoint inhibitors in anal squamous cell carcinoma: a systematic review and meta-analysis by Pala, Laura, De Pas, Tommaso, Stucchi, Erika, Catania, Chiara, Cocorocchio, Emilia, Zampino, Maria Giulia, Rossi, Giovanna, Zattarin, Emma, Di Muzio, Antonio, Laszlo, Daniele, Stucchi, Sara, Conforti, Fabio

“…Squamous cell carcinoma of the anus (SCCA) is a rare tumor. While most patients with locally advanced disease are cured with chemo-radiotherapy, about a…”
Get full text

A reappraisal of the histopathologic criteria for the diagnosis of cutaneous allogeneic acute graft-vs-host disease by MASSI, D, FRANCHI, A, PIMPINELLI, N, LASZLO, D, BOSI, A, SANTUCCI, M

“…To determine the validity of the Lerner grading system and review the histopathologic findings of cutaneous acute graft-vs-host disease (aGVHD), 78 skin biopsy…”
Get full text

"Fludarabine Containing-Regimens May Adversely Affect Peripheral Blood Stem Cell Collection in Low-Grade Non Hodgkin Lymphoma Patients" by Laszlo, Daniele, Galieni, Piero, Raspadori, Donatella, Scalia, Giulia, Bigazzi, Catia, Bocchia, Monica, Bucalossi, Alessandro, Marotta, Giuseppe, Tozzi, Monica, Lauria, Francesco

“…Fludarabine (FLUDA) based chemotherapy has shown promise in both initial and salvage treatment of low-grade non Hodgkin's lymphomas (LG-NHL). Recently, more…”
Get full text

A Cellular Therapy with Haploidentical Peripheral Hematopoietic STEM CELL Transplantation MAY be a Therapeutic Option in Patients with Relapsed Lymphoma with Chemorefractory Disease by Sammassimo, Simona, Avenoso, Daniele, Gigli, Federica, Laszlo, Daniele, Bertolini, Francesco, Russo, Giammarco, Tarella, Corrado, Pastano, Rocco

“…Background: haploidentical hematopoietic stem cell transplant (HSCT) with post-transplant cyclophosphamide (Cy) is a procedure for patients with advanced…”
Get full text

Fine-Tuning Adjuvant Endocrine Therapy for Early-Stage Breast Cancer: An Expert Consensus on Open Issues for Future Research by Conforti, Fabio, Pala, Laura, De Pas, Tommaso, Zattarin, Emma, Catania, Chiara, Cocorocchio, Emilia, Rossi, Giovanna, Laszlo, Daniele, Colleoni, Marco, Zambelli, Alberto, Hortobagyi, Gabriel N, Cortes, Javier, Piccart, Martine J, Dowsett, Mitch, Gelber, Richard D, Viale, Giuseppe

“…After decades of research, improving the efficacy of adjuvant endocrine therapy (ET) for early-stage breast cancer becomes increasingly difficult. Beyond…”
Get full text

Improved outcomes in women with BRAF-mutant melanoma treated with BRAF/MEK-targeted therapy across randomized clinical trials. A systematic review and meta-analysis by Pala, Laura, De Pas, Tommaso, Pagan, Eleonora, Minucci, Saverio, Catania, Chiara, Digiacomo, Nunzio, Cocorocchio, Emilia, Laszlo, Daniele, Di Muzio, Antonio, Barigazzi, Chiara, Stucchi, Erika, De Grandi, Laura, Stucchi, Sara, Viale, Giuseppe, Gelber, Richard D., Bagnardi, Vincenzo, Conforti, Fabio

“…Available evidence suggests that in patients with advanced BRAF V600-mutant melanoma treated with the combination of BRAF and MEK inhibitors, gender could be…”
Get full text

Midline catheter as effective device in healthy allogeneic donors and patients without an adequate peripheral venous access for HPC collection by apheresis: Preliminary experience at IEO by Caime, Alessandro, Piredda, Alessio, Lucchetti, Bruno, Magarò, Antonio, Zencovich, Claudia, Clerici, Margerita, Laszlo, Daniele

“…Collection of HPC by apheresis requires adequate venous access for inflow and for outflow. The use of midline has never been reported in this setting. We…”
Get full text